Showing results (21-30 of 340) with videos related to
Sort By:
Pageof 34
Journal of the American Society of Nephrology : JASN|July 11, 2006
Microalbuminuria as an early marker for cardiovascular diseaseDick de Zeeuw, Hans-Henrik Parving, Robert H HenningJournal of Hypertension|September 4, 2009
Renal and cardio-protective effects of direct renin inhibition: a systematic literature reviewHiddo J Lambers Heerspink, Vlado Perkovic, Dick de ZeeuwHypertension (Dallas, Tex. : 1979)|March 19, 2003
Coronary myogenic constriction antagonizes EDHF-mediated dilation: role of KCa channelsSimone Gschwend, Robert H Henning, Dick de Zeeuw, et al.Kidney International. Supplement|August 20, 2005
The kidney, a cardiovascular risk marker, and a new target for therapyDick de Zeeuw, Hans L Hillege, Paul E de JongNature Reviews. Nephrology|December 4, 2013
The effect of RAAS blockade on the progression of diabetic nephropathySara S Roscioni, Hiddo J Lambers Heerspink, Dick de ZeeuwCurrent Hypertension Reports|March 13, 2009
Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?Stephan J L Bakker, Ron T Gansevoort, Dick de ZeeuwKidney International|April 25, 2014
Microalbuminuria: target for renoprotective therapy PROSara S Roscioni, Hiddo J Lambers Heerspink, Dick de ZeeuwPlos One|October 17, 2012
The geographical distribution of leadership in globalized clinical trialsJarno Hoekman, Koen Frenken, Dick de Zeeuw, et al.Current Opinion in Nephrology and Hypertension|February 22, 2002
Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variabilityMenno J A Kocks, Dick de Zeeuw, Gerjan J NavisKidney International|November 4, 2020
New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reductionHiddo J L Heerspink, Donald E Kohan, Dick de ZeeuwPageof 34